PL2531172T3 - Kompozycja farmaceutyczna o działaniu przeciw otyłości zawierająca mieszaninę wstępną czystego orlistatu i sposób przygotowania - Google Patents
Kompozycja farmaceutyczna o działaniu przeciw otyłości zawierająca mieszaninę wstępną czystego orlistatu i sposób przygotowaniaInfo
- Publication number
- PL2531172T3 PL2531172T3 PL10709955T PL10709955T PL2531172T3 PL 2531172 T3 PL2531172 T3 PL 2531172T3 PL 10709955 T PL10709955 T PL 10709955T PL 10709955 T PL10709955 T PL 10709955T PL 2531172 T3 PL2531172 T3 PL 2531172T3
- Authority
- PL
- Poland
- Prior art keywords
- premixture
- pharmaceutical composition
- preparation process
- obesity activity
- pure orlistat
- Prior art date
Links
- 230000003579 anti-obesity Effects 0.000 title 1
- 230000000694 effects Effects 0.000 title 1
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 title 1
- 229960001243 orlistat Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Child & Adolescent Psychology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2010/000579 WO2011091816A1 (en) | 2010-02-01 | 2010-02-01 | Pharmaceutical composition with anti-obesity activity comprising a premixture of pure orlistat and preparation process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2531172T3 true PL2531172T3 (pl) | 2017-07-31 |
Family
ID=43126897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10709955T PL2531172T3 (pl) | 2010-02-01 | 2010-02-01 | Kompozycja farmaceutyczna o działaniu przeciw otyłości zawierająca mieszaninę wstępną czystego orlistatu i sposób przygotowania |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8685449B2 (pl) |
| EP (1) | EP2531172B1 (pl) |
| CN (1) | CN102740831B (pl) |
| AR (1) | AR078940A1 (pl) |
| BR (1) | BR112012018696B1 (pl) |
| CL (1) | CL2012002077A1 (pl) |
| ES (1) | ES2609018T3 (pl) |
| MX (1) | MX2012008861A (pl) |
| PH (1) | PH12012501512A1 (pl) |
| PL (1) | PL2531172T3 (pl) |
| UA (1) | UA107369C2 (pl) |
| WO (1) | WO2011091816A1 (pl) |
| ZA (1) | ZA201205769B (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102552168B (zh) * | 2012-01-31 | 2013-08-07 | 杭州华东医药集团生物工程研究所有限公司 | 一种含有奥利司他的药物组合物及其制备方法 |
| CN106309565A (zh) * | 2015-06-29 | 2017-01-11 | 北京海吉星医疗科技有限公司 | 一种贞芪扶正缓释滴丸及其制备方法 |
| RU2762552C2 (ru) * | 2020-10-05 | 2021-12-21 | Общество с ограниченной ответственностью "Гротекс" (ООО "Гротекс") | Фармацевтическая композиция оксиэтиламмония метилфеноксиацетата |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI54811C (fi) | 1972-06-03 | 1979-03-12 | Vega Jose Manuel Regife | Foerfarande foer tillvaratagning och rening av zink fraon zinkhaltiga loesningar |
| CA1247547A (en) | 1983-06-22 | 1988-12-28 | Paul Hadvary | Leucine derivatives |
| US6004996A (en) * | 1997-02-05 | 1999-12-21 | Hoffman-La Roche Inc. | Tetrahydrolipstatin containing compositions |
| AR025609A1 (es) | 1999-09-13 | 2002-12-04 | Hoffmann La Roche | Formulaciones lipidas solidas |
| WO2006110809A2 (en) * | 2005-04-12 | 2006-10-19 | Elan Pharma International, Limited | Nanoparticulate lipase inhibitor formulations |
| WO2009044380A2 (en) * | 2007-10-05 | 2009-04-09 | Ranbaxy Laboratories Limited | Formulations containing orlistat particles having controlled particle size |
| PL216542B1 (pl) | 2008-03-20 | 2014-04-30 | Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna | Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku |
-
2010
- 2010-01-02 UA UAA201209384A patent/UA107369C2/ru unknown
- 2010-02-01 WO PCT/EP2010/000579 patent/WO2011091816A1/en not_active Ceased
- 2010-02-01 MX MX2012008861A patent/MX2012008861A/es active IP Right Grant
- 2010-02-01 PH PH1/2012/501512A patent/PH12012501512A1/en unknown
- 2010-02-01 US US13/576,606 patent/US8685449B2/en active Active
- 2010-02-01 CN CN201080062683.3A patent/CN102740831B/zh not_active Expired - Fee Related
- 2010-02-01 BR BR112012018696-5A patent/BR112012018696B1/pt not_active IP Right Cessation
- 2010-02-01 PL PL10709955T patent/PL2531172T3/pl unknown
- 2010-02-01 ES ES10709955.8T patent/ES2609018T3/es active Active
- 2010-02-01 EP EP10709955.8A patent/EP2531172B1/en active Active
- 2010-11-08 AR ARP100104140A patent/AR078940A1/es not_active Application Discontinuation
-
2012
- 2012-07-26 CL CL2012002077A patent/CL2012002077A1/es unknown
- 2012-07-31 ZA ZA2012/05769A patent/ZA201205769B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112012018696B1 (pt) | 2019-07-02 |
| ES2609018T3 (es) | 2017-04-18 |
| EP2531172A1 (en) | 2012-12-12 |
| US20120294941A1 (en) | 2012-11-22 |
| WO2011091816A1 (en) | 2011-08-04 |
| CL2012002077A1 (es) | 2012-12-07 |
| UA107369C2 (en) | 2014-12-25 |
| AR078940A1 (es) | 2011-12-14 |
| CN102740831B (zh) | 2015-01-28 |
| US8685449B2 (en) | 2014-04-01 |
| BR112012018696A2 (pt) | 2016-05-03 |
| ZA201205769B (en) | 2013-04-24 |
| CN102740831A (zh) | 2012-10-17 |
| PH12012501512A1 (en) | 2016-07-29 |
| EP2531172B1 (en) | 2016-10-12 |
| MX2012008861A (es) | 2013-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201300002B (en) | Novel processes for the preparation of phenylcyclopropylamine derivatives and use thereof for preparing ticagrelor | |
| IL221041A0 (en) | Solid pharmaceutical composition with enhancers and methods of preparing thereof | |
| GB201110850D0 (en) | Catalyst and mehtod of preparation | |
| PL2643010T3 (pl) | Biologicznie aktywny kompleks i jego otrzymywanie | |
| IL230855A0 (en) | Cabazitaxel formulations and methods for their preparation | |
| GB201104473D0 (en) | Improved pharmaceutical compositions and methods of delivery | |
| IL222576A0 (en) | Fexofenadine-based composition and preparation process therefor | |
| IL233290A0 (en) | Preparation composition, and use of dense chitosan membrane materials | |
| EP2766375A4 (en) | PREPARATION OF NEW FLUORIN COMPOUNDS, METHOD OF MANUFACTURING AND COMPOSITIONS MADE THEREOF | |
| ZA201405039B (en) | Pharmaceutical preparation comprising brexpiprazole and substituted beta - cyclodextrin | |
| PL2678244T3 (pl) | Pakiet do parzenia i jego wytwarzanie | |
| EP2581369A4 (en) | METHOD OF MANUFACTURING DRONEDARON AND ITS SALTS | |
| ZA201306905B (en) | Novel octahydrothienoquinonline derivative,pharmaceutical composition comprising derivative, and use of these | |
| IL231505B (en) | Pharmaceutical preparation and method for its production | |
| ZA201305277B (en) | Phenyl-isoxazol derivatives and preparation process thereof | |
| LT2640422T (lt) | Veikliųjų medžiagų polimeriniai konjugatai, jų gamybos būdas ir jų polimeriniai tarpiniai junginiai | |
| EP2734513A4 (en) | INTERMEDIATE PRODUCT OF STATIN MEDICINES AND THEIR MANUFACTURE | |
| EP2701689A4 (en) | PHARMACEUTICAL COMPOSITIONS OF RALTEEGRAVIR, METHODS OF PREPARATION AND USE THEREOF | |
| ZA201205769B (en) | Pharmaceutical composition with anti-obesity activity comprising a premixture of pure orlistat and preparation process | |
| HRP20180781T1 (hr) | Farmaceutski pripravak koji sadržava lidipidipin i proces pripreme | |
| EP2640674B8 (en) | Manner of obtainment of mass for production of shaped construction elements and mass for production of shaped construction elements | |
| AU2010900810A0 (en) | Production of serrulatane diterpenes and analogues | |
| AU2010905364A0 (en) | Production of serrulatane diterpenes and analogues | |
| GB201112578D0 (en) | Pharmaceutical preparation and use | |
| HK1178075A (en) | Pharmaceutical composition and dosage forms of elinogrel and methods of use thereof |